17Mar 2014
HIKMA filling the gaps when bigger operators have plant problems and drug shortages arise FiercePharma Manufacturing, 13. March 2014 By Eric Palmer Middle East-based Hikma Pharmaceuticals is not a large pharma player. The drugmaker’s $1.365 billion in 2013 revenues is about what a Big Pharma company would report for sales of one drug. But it […]